Analize Laborator - Alfabet
| Echinococcus granulosus (EGRH)* | 133 | 129 | 3442 |
| Echinococcus granulosus Ac IgG - Westernblot (ECHGW)** | 260 | 255 | 5934 |
| Echinococcus granulosus/multilocularis Ac IgG - screening** | 70 | 67 | 5953 |
| Echinococcus granulosus/multilocularis ADN-PCR in LCR (ECHPCL)* | 1431 | 1416 | 3437 |
| Echinococcus multilocularis Ac IgG - Westernblot (EMUW)** | 260 | 255 | 5944 |
| Echinococcus multilocularis Ac IgG (EMUE)* | 133 | 129 | 2643 |
| Ehrlichia Ac IgG (EHRGI)* | 111 | 107 | 1506 |
| Ehrlichia Ac IgM (EHRMI)* | 111 | 107 | 1507 |
| Ehrlichia ADN-PCR in capusa (Anaplasma phagocytophilum / Ehrlichia canis) (EHRPCZ)* | 332 | 325 | 4736 |
| Ehrlichia ADN-PCR in sange / lichid de punctie (Anaplasma phagocytophilum / Ehrlichia canis) (EHRPCR)* | 441 | 432 | 4737 |
| Elastaza pancreatica in materii fecale (BELA1S)* | 155 | 150 | 1716 |
| Elastaza pancreatica in ser (ELA1)* | 196 | 190 | 1569 |
| Electroforeza hemoglobinei** | 64 | 61 | 2377 |
| Electroforeza LDL - profil 7 clase LDL (LIPGEL)* | 495 | 485 | 2260 |
| Electroforeza lipoproteinelor* | 185 | 179 | 1788 |
| Electroforeza MPS in urina (MPS)* | 290 | 284 | 2258 |
| Electroforeza proteinelor serice | 42 | 40 | 65 |
| Electroforeza proteinelor serice cu imunofixare (IMFI)* | 143 | 138 | 4965 |
| Electroforeza proteinelor urinare cu imunofixare (proteine Bence-Jones) (IMFIU)* | 175 | 169 | 1635 |
| ENA Panel (Centromer B IgG-Ac, Chromatin (nucl.) Ac, SS-A/Ro, La/SS-B, Sm, RNP, U1-RNP/SM, Scl-70, Jo-1, Ribosomal P-protein Ac) - metoda FCM (AENABP)* | 176 | 170 | 2410 |
| Enalapril (ENALA)* | 390 | 382 | 3284 |
| Entacapon (ENTAC)* | 400 | 392 | 4850 |
| Entamoeba hystolytica - Antigen in materii fecale (ENHI)* | 106 | 102 | 1579 |
| Enterovirus Ac IgG (echo-, coxsackie-, enterovirus grup 68-71) (ENTGE)* | 117 | 113 | 1750 |
| Enterovirus Ac IgM (echo-, coxsackie-, enterovirus grup 68-71) (ENTME)* | 111 | 107 | 1751 |
| Enterovirus ARN-PCR - diferentiere in materii fecale* | 419 | 410 | 3266 |
| Enterovirus ARN-PCR (Coxsackie, Echo, Polio, Rhino) (ENTPCR)* | 463 | 453 | 2532 |
| Enterovirus ARN-PCR in LCR (Coxsackie, Echo, Polio, Rhino) (ENTPCL)* | 430 | 421 | 2755 |
| Enterovirus ARN-PCR in materii fecale (Coxsackie, Echo, Polio, Rhino) (ENPCST)* | 447 | 438 | 3127 |
| EPCR - mutatiile genei receptorului proteinei C (A4600G/G4678C) | 350 | 340 | 6036 |
| EPCR (secventierea genei receptorului proteinei C)** | 700 | 700 | 3243 |
| Epidermoliza buloasa - panel complex de 26 gene - PLUS, SEQ, DEL/DUP (DE0301)* | 4600 | 4600 | 5615 |
| Epilepsie - panel complex de 511 de gene - PLUS, SEQ, DEL/DUP (NE1001)* | 5200 | 5200 | 5430 |
| Epstein Barr Virus - Early Antigen Ac IgG (EAE)* | 80 | 76 | 3656 |
| Epstein Barr Virus Ac IgG - Westernblot (EBVGB)* | 172 | 166 | 3259 |
| Epstein Barr Virus ADN-PCR (EBVPCR)* | 243 | 238 | 1505 |
| Epstein Barr Virus ADN-PCR cantitativ (EBVQ)* | 419 | 410 | 3063 |
| Epstein Barr Virus ADN-PCR in LCR (EBVPCL)* | 326 | 319 | 2754 |
| Epstein Barr Virus EBNA 1 Ac IgG** | 84 | 80 | 2809 |
| Epstein Barr Virus EBV IgG test de aviditate si immunoblot (EBVAV)* | 381 | 373 | 5493 |
| Epstein Barr Virus VCA Ac IgG** | 65 | 62 | 2127 |
| Epstein Barr Virus VCA Ac IgM** | 65 | 62 | 2128 |
| Eritropoietina - dozare in ser (EPO)* | 205 | 200 | 1457 |
| Escitalopram + metabolitul Desmetilcitalopram (ESCITA)* | 387 | 379 | 4773 |
| Eslicarbazepin (ESLIC)* | 137 | 132 | 4762 |
| Estradiol (17 beta) | 54 | 51 | 73 |
| Estradiol in saliva (E2SL)* | 200 | 194 | 4747 |
| Estradiol in urina (E2U)* | 200 | 194 | 5948 |
| Estriol in urina (E3U)* | 160 | 155 | 5949 |
| Estriol neconjugat | 58 | 55 | 74 |
| Estrone (E1)* | 195 | 189 | 1334 |
| Ethosuximid (ETHOS)* | 495 | 485 | 5726 |
| Ethylglucuronid (EtG) in ser - (metabolit al alcoolului Etilic) (EGL)* | 428 | 419 | 3575 |
| Ethylglucuronid (EtG) in urina - (metabolit al alcoolului Etilic) (EGLUUK)* | 439 | 430 | 3574 |
| Etilenglicol (EGLY)* | 428 | 419 | 2811 |
| Etilglucuronid in firul de par (evaluarea consumului cronic de alcool) (EGLH)* | 544 | 533 | 5542 |
| Etilsulfat in urina (alcoolism) (ETSU)* | 615 | 602 | 4890 |
| Evaluarea nivelului de stres - Cortizol salivar si DHEA-S salivar* | 885 | 867 | 5863 |
| Evaluarea riscului de pre-eclampsie (PLGF+sFlt1+ratio) (SFPLR)* | 450 | 441 | 2068 |
| Everolimus (EVERO)* | 192 | 186 | 3078 |
| Ex.Babes-Papanicolaou* | 75 | 72 | 155 |
| Ex.Babes-Papanicolaou in mediu lichid* | 130 | 126 | 1939 |
| Ex.bacteriologic - alte produse biologice** | 67 | 64 | 3021 |
| Ex.bacteriologic - aspirat bronsic** | 67 | 64 | 4613 |
| Ex.bacteriologic - aspirat gastric** | 67 | 64 | 4586 |
| Ex.bacteriologic - lapte matern** | 67 | 64 | 5314 |
| Ex.bacteriologic - LCR** | 67 | 64 | 4589 |
| Ex.bacteriologic - lichid punctie** | 67 | 64 | 1244 |
| Ex.bacteriologic - prelevat tegumentar** | 67 | 64 | 2875 |
| Ex.bacteriologic - sant balanopreputial** | 67 | 64 | 2606 |
| Ex.bacteriologic - screening ESBL (Enterobacterii producatoare de beta-lactamaze cu spectru extins)** | 45 | 43 | 5724 |
| Ex.bacteriologic - screening Staphylococcus aureus MRSA (pachet preoperator axila)** | 67 | 64 | 5315 |
| Ex.bacteriologic - screening Staphylococcus aureus MRSA (pachet preoperator inghinal)** | 67 | 64 | 5316 |
| Ex.bacteriologic - secretie col uterin | 65 | 62 | 1275 |
| Ex.bacteriologic - secretie conjunctivala | 65 | 62 | 1236 |
| Ex.bacteriologic - secretie mamara** | 65 | 62 | 1796 |
| Ex.bacteriologic - secretie nazala | 55 | 52 | 1235 |
| Ex.bacteriologic - secretie nazala (nara dreapta, nara stanga) | 85 | 81 | 3215 |
| Ex.bacteriologic - secretie otica | 65 | 62 | 1234 |
| Ex.bacteriologic - secretie prostatica** | 67 | 64 | 2603 |
| Ex.bacteriologic - secretie uretrala | 65 | 62 | 1233 |
| Ex.bacteriologic - secretie vaginala | 65 | 62 | 1231 |
| Ex.bacteriologic - secretie vulvara | 65 | 62 | 1789 |
| Ex.bacteriologic - secretii purulente/plagi/fistule/abcese | 65 | 62 | 1954 |
| Ex.bacteriologic - sputa | 65 | 62 | 1225 |
| Ex.bacteriologic secretie nazala-screening MRSA (pachet preoperator)** | 67 | 64 | 5590 |
| Ex.citologic - diverse produse* | 100 | 96 | 4696 |
| Ex.citologic al frotiului sanguin | 40 | 38 | 29 |
| Ex.citologic din lichid punctie* | 110 | 106 | 1647 |
| Ex.citologic din punctie tiroida* | 145 | 140 | 3296 |
| Ex.citologic din secretie mamara* | 95 | 91 | 1549 |
| Ex.citologic din sputa* | 88 | 84 | 3257 |
| Ex.coproparazitologic proba I | 25 | 24 | 217 |
| Ex.coproparazitologic proba II | 25 | 24 | 572 |
| Ex.coproparazitologic proba III | 25 | 24 | 574 |
| Ex.micologic - alte produse biologice** | 65 | 62 | 2361 |
| Ex.micologic - aspirat gastric** | 65 | 62 | 4591 |
| Ex.micologic - LCR** | 65 | 62 | 4590 |
| Ex.micologic - lichid punctie** | 65 | 62 | 2146 |
| Ex.micologic - prelevat tegumentar** | 65 | 62 | 4587 |
| Ex.micologic - sant balanopreputial** | 65 | 62 | 2607 |
| Ex.micologic - scuame** | 65 | 62 | 1542 |
| Ex.micologic - secretie col uterin | 65 | 62 | 2145 |
| Ex.micologic - secretie conjunctivala | 65 | 62 | 2149 |
| Ex.micologic - secretie mamara** | 65 | 62 | 2147 |
| Ex.micologic - secretie nazala | 65 | 62 | 2150 |
| Ex.micologic - secretie otica | 65 | 62 | 2151 |
| Ex.micologic - secretie prostatica** | 65 | 62 | 2604 |
| Ex.micologic - secretie uretrala | 65 | 62 | 2152 |
| Ex.micologic - secretie vaginala | 65 | 62 | 1232 |
| Ex.micologic - secretie vulvara | 65 | 62 | 2148 |
| Ex.micologic - secretii purulente/plagi/fistule/abcese | 65 | 62 | 2143 |
| Ex.micologic - sputa | 65 | 62 | 1226 |
| Ex.micologic - unghie** | 65 | 62 | 2470 |
| Ex.micologic - urina | 65 | 62 | 3019 |
| Ex.micologic dermatofiti - diverse produse biologice** | 85 | 81 | 5700 |
| Ex.microscopic - LCR** | 33 | 31 | 4592 |
| Ex.microscopic - prelevat tegumentar** | 33 | 31 | 4585 |
| Ex.microscopic colorat - alte produse biologice** | 33 | 31 | 3022 |
| Ex.microscopic colorat - aspirat gastric** | 33 | 31 | 4593 |
| Ex.microscopic colorat - lichid de punctie** | 33 | 31 | 1243 |
| Ex.microscopic colorat - sant balanopreputial** | 33 | 31 | 2608 |
| Ex.microscopic colorat - secretie col uterin | 33 | 31 | 1274 |
| Ex.microscopic colorat - secretie conjunctivala | 33 | 31 | 1241 |
| Ex.microscopic colorat - secretie linguala | 33 | 31 | 2486 |
| Ex.microscopic colorat - secretie mamara** | 33 | 31 | 3228 |
| Ex.microscopic colorat - secretie otica | 33 | 31 | 1239 |
| Ex.microscopic colorat - secretie prostatica** | 33 | 31 | 2605 |
| Ex.microscopic colorat - secretie uretrala | 33 | 31 | 1238 |
| Ex.microscopic colorat - secretie vaginala | 33 | 31 | 1230 |
| Ex.microscopic colorat - secretie vulvara | 33 | 31 | 1790 |
| Ex.microscopic colorat - secretii nazale | 33 | 31 | 1240 |
| Ex.microscopic colorat - secretii purulente/plagi/fistule/abcese | 33 | 31 | 2056 |
| Ex.microscopic colorat - sputa | 33 | 31 | 1224 |
| Ex.microscopic colorat - urina | 33 | 31 | 3105 |
| Ex.microscopic direct - dermatofiti - diverse produse biologice** | 55 | 52 | 5709 |
| Ex.microscopic eozinofile - secretie nazala (nara dreapta, nara stanga)** | 50 | 48 | 5725 |
| Examen complet urina (sumar si sediment) | 34 | 32 | 151 |
| Examen din secretii vaginale portaj Streptococcus agalactiae, prin metode de cultivare** | 65 | 62 | 5757 |
| Examen din tampon rectal portaj Streptococcus agalactiae, prin metode de cultivare** | 65 | 62 | 5758 |
| Examen histopatologic - a doua opinie (o piesa)* | 1300 | 1287 | 5568 |
| Examen imunohistochimic - a doua opinie (o piesa)* | 1300 | 1287 | 5588 |
| Examen imunohistochimic - studiul receptorilor hormonali* | 935 | 916 | 5067 |
| Examen imunohistochimic set 5 anticorpi* | 765 | 749 | 5418 |
| Examen sumar de urina | 31 | 29 | 3020 |
| Examinare histopatologica piesa mare (peste 5 blocuri de parafina)* | 535 | 524 | 5075 |
| Examinare histopatologica piesa medie (4-5 blocuri de parafina)* | 385 | 377 | 5074 |
| Examinare histopatologica piesa mica (1-3 blocuri de parafina)* | 275 | 269 | 5073 |
| Exsudat faringian - ex.bacteriologic | 55 | 52 | 1221 |
| Exsudat faringian - ex.micologic | 65 | 62 | 1222 |
| Exsudat faringian - ex.microscopic colorat | 33 | 31 | 159 |
| Exsudat lingual - ex.micologic | 65 | 62 | 2144 |
| Exsudat nazal - identificare extinsa si antibiograma (Staphylococcus aureus, Streptococcus pyogenes, Moraxella catharallis, Streptococcus pneumoniae, Haemophillus spp.)** | 65 | 62 | 4514 |
| 1,25 dihidroxi Vitamina D** | 220 | 215 | 1343 |
| 11-Deoxycorticosteron in ser (DOC)* | 387 | 379 | 2038 |
| 11-Deoxycortisol in ser (DCORT)* | 245 | 240 | 2036 |
| 7-dehidrocolesterol in lichid amniotic (sindrom Smith-Lemli-Opitz)* | 605 | 592 | 5106 |
| D-Dimeri** | 75 | 72 | 1468 |
| DDT (Diclor-Difenil-Tricloretanul)* | 428 | 419 | 4840 |
| Deficienta GLUT 1 - MLPA* | 1950 | 1950 | 5209 |
| Deficienta GLUT 1 (gena SLC2A1) - secventiere* | 950 | 950 | 4770 |
| Deficienta lipazei acide lizozomale - boala Wolman* | 3825 | 3825 | 3422 |
| Deficienta MCAD (gena ACADM) - secventiere exoni 1-10 si 12 - etapa 2* | 8550 | 8550 | 2339 |
| Deficienta MCAD (gena ACADM) - secventiere Lys329Glu (=K304E) - etapa 1* | 969 | 969 | 2338 |
| Deficit 5 alfa-reductaza tip 2 (SRD5A2), secventiere* | 1500 | 1500 | 4812 |
| Deficit 5 alfa-reductaza tip 2- panel* | 25000 | 25000 | 4813 |
| Deficit de biotinidaza (gena BTD) - secventiere ADN* | 3600 | 3600 | 3003 |
| Deficitul de fumaraza - gena FH - transmitere AR - secventiere Sanger* | 1450 | 1450 | 5020 |
| Deficitul de Glucozo-6-Fosfat-Dehidrogenaza - gena G6PD - secventiere* | 1650 | 1650 | 5262 |
| Deficitul de ornitin transcarbamilaza OTC - secventiere* | 1450 | 1450 | 5275 |
| Deficitul de piridoxamin-5-fosfat oxidaza (PNPO) - secventiere* | 1200 | 1200 | 5311 |
| Deficitul de VLCAD - acizi grasi cu lant foarte lung (VLCFA) (ALD)* | 462 | 452 | 2646 |
| Del17p-FISH in frotiu de maduva osoasa* | 770 | 770 | 2904 |
| Del17p-FISH in sange heparinat* | 1300 | 1300 | 2905 |
| Dementa - panel complex de 58 de gene - PLUS, SEQ, DEL/DUP (NE2301)* | 4600 | 4600 | 5478 |
| Dengue fever virus Ac IgM (DENME)* | 110 | 106 | 2902 |
| Dengue fever virus antigen (DENAGE)* | 128 | 124 | 4957 |
| Dengue fever virus IgG (DENGE)* | 110 | 106 | 4955 |
| Dengue fever virus RNA - PCR (DENPCR)* | 1046 | 1035 | 4956 |
| Detectarea si izolarea ADN uman din diverse produse* | 1220 | 1159 | 6060 |
| Detectia de anticorpi anti Salmonella spp. (GAM)* | 205 | 200 | 5376 |
| Detectia de anticorpi anti Salmonella spp. IgA* | 216 | 211 | 5375 |
| Detectia de anticorpi anti Yersinia enterocolitica IgA* | 180 | 174 | 5373 |
| Detectia de anticorpi anti Yersinia enterocolitica IgG* | 180 | 174 | 5374 |
| Detectia de anticorpi anti Yersinia enterocolitica IgM* | 180 | 174 | 5909 |
| Detectie SARS-CoV-2 ARN prin tehnici moleculare (RT-PCR/RT-TMA)* | 230 | 225 | 5188 |
| Determinare Ac. anti Bacillus anthracis* | 265 | 259 | 5377 |
| Determinare anticorpi anti-Brucella in ser (Reactia Huddleson)* | 220 | 215 | 5371 |
| Determinare anticorpi anti-Brucella in ser (Reactia Wright)* | 221 | 216 | 5372 |
| Determinare creatina (KRET)* | 231 | 226 | 5496 |
| Determinare factor Rho(D) | 50 | 48 | 31 |
| Determinare grup sangvin (A,B,O) | 32 | 30 | 32 |
| DHEA Dehidro-epiandrosteron (DHEA)* | 78 | 74 | 1391 |
| DHEA Dehidro-epiandrosteron in urina (DHEAUT)* | 200 | 194 | 5974 |
| DHEA-S Dehidro-epiandrosteron-sulfat | 55 | 52 | 71 |
| Diabet MODY - screening MLPA pentru tipurile 1, 2, 3 si 5* | 2025 | 2025 | 3341 |
| Diabet MODY - secventierea completa a genelor HNF1A si GCK, si analiza MLPA (tip 2 si 3)* | 16500 | 16500 | 3332 |
| Diabet MODY tip 1 - analiza MLPA a genei HNF4A* | 2025 | 2025 | 3334 |
| Diabet MODY tip 1 - secventierea genei HNF4A* | 8200 | 8200 | 3333 |
| Diabet MODY tip 2 - analiza MLPA a genei GCK* | 2025 | 2025 | 3336 |
| Diabet MODY tip 2 - secventierea genei GCK* | 8200 | 8200 | 3335 |
| Diabet MODY tip 3 - analiza MLPA a genei HNF1A (=TCF1)* | 2025 | 2025 | 3338 |
| Diabet MODY tip 3 - secventierea genei HNF1A (=TCF1)* | 8200 | 8200 | 3337 |
| Diabet MODY tip 5 - analiza MLPA a genei HNF1B* | 2025 | 2025 | 3340 |
| Diabet MODY tip 5 - secventierea genei HNF1B* | 8000 | 8000 | 3339 |
| Diagnostic CLN (Lipofuscinoza ceroida neuronala) infantila-tardiva si timpurie - dozare enzimatica palmitoil-protein-tioesteraza si tripeptidil-peptidaza (BUCNCL)* | 715 | 700 | 3655 |
| Diagnostic Glicogenoza - Boli cu stocare de glicogen in ficat (GSDPRL)* | 6050 | 5989 | 3650 |
| Diagnostic Glicogenoza - Boli cu stocare de glicogen in ficat TIP I (GSDT1)* | 963 | 943 | 3653 |
| Diagnosticarea sindromului CDG (tulburare congenitala a glicozilarii) (CDGS)* | 458 | 448 | 5748 |
| Diagnosticul CDG - activitatea enzimatica a fosfomanomutazei si fosfomanozizomerazei* | 2420 | 2395 | 3117 |
| Diagnosticul CDG (tulburare congenitala a glicozilarii)* | 396 | 388 | 4758 |
| Diagnosticul molecular al predispozitiei la neuroblastom - gena ALK (CD246) - secventiere* | 11000 | 11000 | 3719 |
| Diamino oxidase concentration (test de intoleranta la histamina) (DAO)** | 165 | 160 | 1431 |
| Diazepam - dozare (DIAZE)* | 425 | 416 | 5614 |
| Diclormetan (clorura de metilen) in sange* | 275 | 260 | 6011 |
| Diclormetan in urina (clorura de metilen) (DCLMU)* | 439 | 430 | 4631 |
| Digoxina - monitorizare (DIGOX)* | 60 | 57 | 1555 |
| Dihidropteridin-reductaza - activitatea enzimatica (DHPRA)* | 200 | 194 | 5786 |
| Dihidrotestosteron (DHT)* | 175 | 169 | 1923 |
| Dimetilarginina asimetrica (ADMA)* | 462 | 452 | 5366 |
| Dirofilaria Anticorpi - screening: Brugia spp., Dirofilaria spp., Loa loa, Mansonella spp., Onchocerca volvulus, Wuchereria bancrofti (FILE)* | 170 | 164 | 5803 |
| Disbioza colonului - analiza microflorei in scaun (SBYA)* | 600 | 588 | 2901 |
| Disbioza colonului - profil atopie (SBYA8)* | 1650 | 1633 | 3674 |
| Disbioza colonului - profil boli intestinale cronice (SBYA3)* | 980 | 960 | 3622 |
| Disbioza colonului - profil de baza (SBYA1)* | 1000 | 990 | 3405 |
| Disbioza colonului - profil enterita (SBYA4)* | 1250 | 1237 | 5705 |
| Disbioza colonului - profil hemoragii oculte/suspiciune tumora (SBYA6)* | 320 | 313 | 3671 |
| Disbioza colonului - profil sindrom colon iritabil (SBYA2)* | 1400 | 1386 | 3411 |
| Disbioza colonului - profil sindrom intestin permeabil (SBYA7)* | 1400 | 1386 | 3672 |
| Disbioza colonului - profil sindrom maldigestie (SBYA5)* | 1000 | 990 | 3668 |
| Dischinezie paroxistica kinezigenica (gena PRRT2) - secventiere* | 930 | 930 | 5085 |
| Disgenezia gonadica - SRY, microdeletia brat scurt cromosom Y p11.3 (cariotipare si 2 teste FISH)* | 2600 | 2600 | 3606 |
| Diskeratosis congenita - panel complex de 15 gene - PLUS, SEQ, DEL/DUP (IM0401)* | 3600 | 3600 | 5464 |
| Displazii si tulburari scheletice - panel complex 411 gene - PLUS, SEQ, DEL/DUP (MA3301)* | 5200 | 5200 | 5607 |
| Distonia - panel complex de 68 de gene - PLUS, SEQ, DEL/DUP (NE2501)* | 4600 | 4600 | 5701 |
| Distonie DYT5 (gena GCH1) - secventiere* | 5200 | 5200 | 3278 |
| Distrofia miotonica de tip 1, boala Steinert - gena DMPK - TP-PCR* | 1000 | 1000 | 5837 |
| Distrofia musculara Emery-Dreifuss - panel 6 gene - PLUS, SEQ, DEL/DUP (NE0301)* | 3600 | 3600 | 5434 |
| Distrofia retiniana ereditara asociata mutatiilor genei RPE65 (terapie genica cu Luxturna) - secventiere Sanger* | 1600 | 1600 | 5093 |
| Distrofie miotonica tip II - etapa 1 (PROMM)* | 1700 | 1700 | 1821 |
| Distrofie miotonica tip II - etapa 2* | 2700 | 2700 | 1822 |
| Distrofie musculara Duchenne/Becker (DMDB)* | 1700 | 1700 | 1644 |
| Distrofie musculara facio-scapulo-humerala - FSHD1 - (Landouzy-Dejerine)* | 3900 | 3800 | 6018 |
| Distrofie musculara si miopatie - panel complex 161 de gene (include miopatie nemalinica, distrofie musculara, Emery-Dreifuss, tulburari de colagen tip VI) - PLUS, SEQ, DEL/DUP (NE0701)* | 5200 | 5200 | 5424 |
| Distrofie musculara tip Emery-Dreifuss - gena LMNA - secventiere* | 6000 | 6000 | 4346 |
| Dopamina (DOPA)* | 208 | 203 | 1633 |
| Doxepina si metabolitul Nordoxepina (DOXE)* | 940 | 921 | 4858 |
| Doxiciclina (DOXYC)* | 230 | 225 | 5817 |
| Dozare uracil - toxicitate tratament 5-fluorouracil deficit DPD (URAC)* | 490 | 480 | 6020 |
| DPD (piridinolina si dezoxipiridinolina) (PYRIDU)* | 235 | 230 | 1408 |
| Droguri in urina screening extins | 150 | 140 | 5946 |
| Droguri in firul de par - screening prin LCMS pentru amfetamine, cannabis (THC), opiacee (morfina, heroina-metaboliti, codeina, dihidrocodeina), metadona si metabolite, benzodiazepine (DROGH)* | 1275 | 1262 | 5342 |
| Droguri in urina** | 106 | 102 | 1364 |
| Dublu test (PAPP-A, Free ß-HCG) | 155 | 150 | 2213 |
| Dublu test cu calcul de risc genetic | 180 | 174 | 1491 |
| 17 cetosteroizi urinari* | 125 | 121 | 5690 |
| C - Peptid | 85 | 81 | 1305 |
| c-ANCA - Anticorpi anti citoplasma neutrofilelor PR3 (ANCAC)* | 83 | 79 | 1373 |
| C1-esterase inhibitor activity (C1EIF)* | 145 | 140 | 1497 |
| C1-esterase inhibitor protein (C1EIP)* | 120 | 116 | 5776 |
| CA 125 (ovar,canale biliare) | 56 | 53 | 90 |
| CA 125 in lichid de punctie (CA125P)* | 90 | 86 | 2882 |
| CA 15.3 (glanda mamara) | 56 | 53 | 91 |
| CA 19.9 (pancreas,esofag,rect) | 56 | 53 | 92 |
| CA 242 (CA242)* | 210 | 205 | 1691 |
| CA 27.29* | 135 | 130 | 5639 |
| CA 50 (CA50)* | 220 | 215 | 1641 |
| CA 72-4 | 66 | 63 | 1263 |
| Cabergolin (CABER)* | 400 | 392 | 4848 |
| Cadmiu in sange (CD)* | 119 | 115 | 1883 |
| Cadmiu in urina (CDU)* | 126 | 122 | 1969 |
| Calcitonina | 75 | 72 | 689 |
| Calciu in sange integral (CAVB)* | 85 | 81 | 3584 |
| Calciu ionic | 19 | 18 | 50 |
| Calciu total | 15 | 14 | 51 |
| Calciu urinar total** | 23 | 22 | 52 |
| Calcul renal/biliar/glanda salivara - analiza fizica si chimica prin Spectrometrie in Infrarosu (STA)* | 176 | 170 | 2407 |
| Calprotectina - test de screening rapid - imunocromatografie** | 112 | 108 | 4994 |
| Calprotectina in materii fecale * | 189 | 183 | 5066 |
| Calprotectina in ser | 145 | 135 | 5998 |
| Campylobacter Ag in materii fecale - test rapid** | 73 | 70 | 5610 |
| Campylobacter jejunii - Antigen in materii fecale (CAMAGE)* | 105 | 101 | 3113 |
| Campylobacter jejunii Ac IgA (CAMAE)* | 105 | 101 | 2816 |
| Campylobacter jejunii Ac IgG (CAMGE)* | 95 | 91 | 2817 |
| Canabis (THC) in urina - screening** | 106 | 102 | 2241 |
| Canabis (THC) in urina, test de confirmare GCMS (CANNUB)* | 221 | 216 | 4947 |
| Canabis in firul de par (CANHAA)* | 386 | 378 | 3391 |
| Canabis, THC in ser (CANNSE)* | 496 | 486 | 2015 |
| Cancerul colorectal ereditar - panel complex de 23 de gene - PLUS, SEQ, DEL/DUP (ON0201)* | 3600 | 3600 | 5451 |
| Cancerul colorectal non-polipozic tip 1 (MSH2) - secventiere* | 3500 | 3500 | 4572 |
| Cancerul colorectal non-polipozic tip 2 (MLH1) - secventiere* | 3500 | 3500 | 4571 |
| Cancerul colorectal nonpolipozic ereditar, genele de predispozitie MLH1, MSH2, MSH6 - MLPA* | 2500 | 2500 | 4781 |
| Cancerul colorectal nonpolipozic ereditar, genele de predispozitie MSH6, EPCAM - MLPA* | 2000 | 2000 | 5509 |
| Cancerul gastrointestinal ereditar - panel complex de 43 de gene - PLUS, SEQ, DEL/DUP (ON1601)* | 4600 | 4600 | 5916 |
| Cancerul pancreatic ereditar - panel complex de 22 de gene - PLUS, SEQ, DEL/DUP (ON0301)* | 3600 | 3600 | 5917 |
| Cancerul pancreatic ereditar - panel secventiere NGS* | 3900 | 3900 | 5578 |
| Cancerul pulmonar (ALK, LSI 2p23) - FISH* | 1250 | 1250 | 4819 |
| Cancerul pulmonar ereditar - panel complex de 5 de gene - PLUS, SEQ, DEL/DUP (ON0401)* | 3600 | 3600 | 5899 |
| Candida albicans - antigen in ser (CAAGE)* | 240 | 235 | 5943 |
| Candida albicans ADN-PCR (CANPCR)* | 694 | 680 | 4442 |
| Capacitatea latenta de legare a fierului-UIBC | 28 | 26 | 2265 |
| Capacitatea oxidativa totala si capacitatea antioxidativa totala (OXBUC)* | 355 | 347 | 4411 |
| Capacitatea totala de legare a fierului-CTLF** | 29 | 27 | 55 |
| Captopril (CAPTO)* | 390 | 382 | 3364 |
| Carbamazepina (CARB)* | 170 | 164 | 1776 |
| Carbidopa (CDOPA)* | 400 | 392 | 4849 |
| Carboanhidraza 1 Ac (CARB1A)* | 132 | 128 | 1599 |
| Carboanhidraza 2 Ac (CARB2A)* | 143 | 138 | 1600 |
| Carboplatina* | 280 | 274 | 3449 |
| Carboxihemoglobina* | 95 | 91 | 5659 |
| Carcinom adenoid chistic (ACC) - mutatii in cromosomul 6 - MYB(6q22-q23) - FISH* | 950 | 931 | 5183 |
| Cardiomiopatia - panel complex de 217 gene - PLUS, SEQ, DEL/DUP (CA1201)* | 5200 | 5200 | 5457 |
| Cardiomiopatia aritmogenica de ventricul drept (ARVC) - panel complex de 21 de gene - PLUS, SEQ, DEL/DUP (CA0401)* | 3600 | 3600 | 5437 |
| Cardiomiopatia dilatativa - panel complex de 130 de gene - PLUS, SEQ, DEL/DUP (CA2201)* | 5200 | 5200 | 5436 |
| Cardiomiopatia hipertrofica - panel complex de 92 de gene - PLUS, SEQ, DEL/DUP (CA1901)* | 4600 | 4600 | 5455 |
| Cardiomiopatia prin non-compactare a ventriculului stang (LVNC) - panel de 32 de gene - PLUS, SEQ, DEL/DUP (CA1801)* | 4600 | 4600 | 5048 |
| Cardiopatia structurala congenitala - panel complex de 125 gene - PLUS, SEQ, DEL/DUP (CA1501)* | 4600 | 4600 | 5441 |
| Cariotip hematologic in maduva osoasa* | 700 | 700 | 5504 |
| Cariotip in cordon ombilical (culturi limfocitare)* | 750 | 750 | 5508 |
| Cariotip in lichid amniotic* | 750 | 750 | 1528 |
| Cariotip in mucoasa coriala* | 750 | 750 | 2133 |
| Cariotip in sange (culturi limfocitare)* | 420 | 420 | 4528 |
| Cariotip postnatal molecular - array CGH (60k)* | 2600 | 2600 | 4419 |
| Cariotip prenatal molecular - array CGH* | 2200 | 2200 | 5512 |
| Carnitina (L-Carnitina) Total/Free in plasma* | 418 | 409 | 5324 |
| Carnitina libera in urina (FCARNU)* | 440 | 431 | 3067 |
| Catecolamine plasmatice - Adrenalina, Noradrenalina, Dopamina (KATEP)* | 250 | 245 | 1446 |
| Catecolamine urinare - Adrenalina, Noradrenalina, Dopamina (CATE)* | 210 | 205 | 1909 |
| Catepsina D (gena CTSD) - secventiere* | 6900 | 6900 | 3598 |
| CBS - Deficit de cistationina beta-sintaza - Homocistinurie (IIe278Thr, Gly307Ser, 844ins68) - screening* | 2150 | 2150 | 5606 |
| CDT-Carbohydrate Deficient Transferrin (CDTEL)* | 182 | 176 | 1863 |
| CEA (antigen carcinoembriogenic) | 56 | 53 | 93 |
| CEA (carcioembrionic Ag) in lichid de punctie (CEAP)* | 56 | 53 | 4826 |
| CEA in LCR (CEAL)* | 70 | 67 | 2747 |
| Ceftazidim (CEFTA)* | 390 | 382 | 5816 |
| Cefuroxim (CEFUR)* | 445 | 436 | 5556 |
| Celule uterine natural killer si plasmocite (PATHV)* | 880 | 862 | 5343 |
| Ceruloplasmina* | 50 | 48 | 1297 |
| CH 50 (CH50)* | 116 | 112 | 1530 |
| Chikungunya virus IgG (CHIGI)* | 177 | 171 | 4958 |
| Chikungunya virus IgM (CHIMI)* | 177 | 171 | 4959 |
| Chitotriozidaza - diagnostic Boala Gaucher (dozare, activitate, raportare la hexozaminidaza) (CHIT)* | 570 | 558 | 5551 |
| Chlamydia pneumoniae Ac IgA (CHPAE)* | 122 | 118 | 1406 |
| Chlamydia pneumoniae Ac IgG (CHPGE)* | 85 | 81 | 1638 |
| Chlamydia pneumoniae Ac IgM* | 165 | 160 | 2002 |
| Chlamydia pneumoniae ADN-PCR (CHPPCR)* | 353 | 345 | 2269 |
| Chlamydia psittaci Ac IgA (CPSAI)* | 204 | 199 | 2246 |
| Chlamydia psittaci Ac IgG (CPSGI)* | 198 | 192 | 2247 |
| Chlamydia psittaci Ac IgM (CPSMI)* | 215 | 210 | 2248 |
| Chlamydia psittaci ADN-PCR (CPSPCR)* | 386 | 378 | 3098 |
| Chlamydia trachomatis - test rapid detectie antigen in secretii genitale | 118 | 114 | 4968 |
| Chlamydia trachomatis - test rapid detectie antigen in urina (barbati)** | 110 | 106 | 4970 |
| Chlamydia trachomatis Ac IgA** | 57 | 54 | 582 |
| Chlamydia trachomatis Ac IgG** | 64 | 61 | 134 |
| Chlamydia trachomatis Ac IgM** | 100 | 96 | 631 |
| Chlamydia trachomatis ADN-PCR** | 165 | 160 | 1712 |
| Chorea Huntington (CHHU)* | 1450 | 1450 | 1624 |
| Chromogranin A (CGA)* | 242 | 237 | 1565 |
| CIC - complexe imune circulante (C1QBI)* | 65 | 62 | 5745 |
| Ciclofosfamida (CPHOS)* | 390 | 382 | 5826 |
| CINtec Plus - Imunocitodiagnostic CIN2+ (p16/Ki67)* | 430 | 421 | 5357 |
| Cipermetrin (CYMET)* | 505 | 494 | 5245 |
| Cisticercoza - Taenia solium IgG in LCR westernblot (CYSEL)* | 435 | 426 | 5892 |
| Cisticercoza - Taenia solium IgG westernblot (CYSW)* | 435 | 426 | 5891 |
| Cistina urinara (CYSU24)* | 176 | 170 | 2618 |
| Cistinoza - gena CTNS - secventiere Sanger* | 1500 | 1500 | 5756 |
| Citocrom P450 Cyp2C9 (CYP2C9)* | 1950 | 1950 | 5834 |
| Citokine intracelulare - profil imunitate TH1-TH2 (TH1TH2)* | 610 | 597 | 2313 |
| Citologie aspirat bronsic* | 88 | 84 | 3640 |
| Citologie urinara* | 116 | 112 | 1956 |
| Citrat urinar (CITU24)* | 130 | 126 | 2099 |
| CK (Creatinfosfokinaza) | 19 | 18 | 43 |
| CK izoenzime - CKMM, CKMB, CKBB (CKISO)* | 220 | 215 | 1697 |
| CK-MB** | 29 | 27 | 632 |
| Clearance creatinina** | 28 | 26 | 11 |
| Clomipramina si metabolitul Norclomipramina si N-Desmetil-Clomipramina (CLOMIP)* | 400 | 392 | 4857 |
| Clonazepam (CLONA)* | 390 | 382 | 4664 |
| Clor | 17 | 16 | 182 |
| Clor in materii fecale (CLST)* | 155 | 150 | 5778 |
| Clor urinar** | 22 | 21 | 1260 |
| Clostridium difficile toxina A/B in materii fecale - imunocromatografie, test rapid** | 121 | 117 | 3651 |
| Clostridium difficile toxina B - PCR in materii fecale (CLDIPC)* | 953 | 933 | 4993 |
| Clostridium difficile toxina in materii fecale - test de confirmare ELISA si cultura (CLDI)* | 127 | 123 | 5265 |
| Clozapina (CLOZA)* | 423 | 414 | 4576 |
| CMV - rezistenta la terapie - genotipare (GCV, FOS, CDV, Letermovir) (CMVRE)* | 8900 | 8900 | 5361 |
| CMV Ac IgG - Westernblot (CMVGW)* | 286 | 280 | 2975 |
| CMV Ac IgM - Westernblot (CMVMW)* | 165 | 160 | 2976 |
| CMV ADN-PCR - calitativ diverse produse biologice (CMVPCR)* | 385 | 377 | 1660 |
| CMV ADN-PCR - cantitativ (CMVQ)* | 385 | 377 | 1279 |
| CMV ADN-PCR in LCR (CMVPCL)* | 392 | 384 | 2937 |
| CMV ADN-PCR in urina (CMVPCU)* | 402 | 393 | 1773 |
| CMV(Citomegalovirus) Ac IgG | 61 | 58 | 119 |
| CMV(Citomegalovirus) Ac IgM | 61 | 58 | 120 |
| CMV(Citomegalovirus) IgG - Indice de aviditate* | 154 | 149 | 1443 |
| Cobalt in sange (COVB)* | 131 | 127 | 1354 |
| Cobalt in urina* | 175 | 169 | 2231 |
| Cocaina (COC) in urina (metaboliti) - screening** | 106 | 102 | 3402 |
| Cocaina in firul de par (COCHAA)* | 397 | 389 | 3399 |
| Cocaina in ser (COCA)* | 870 | 852 | 5362 |
| Coeficient albumina LCR/SER (ALBQL)* | 57 | 54 | 1545 |
| Coeficient de saturatie al transferinei** | 47 | 45 | 1602 |
| Coenzima Q10 (COQ10)* | 235 | 230 | 1893 |
| Colestaza - panel complex de 52 de gene - PLUS, SEQ, DEL/DUP (GA0501)* | 4600 | 4600 | 5473 |
| Colesterol - HDL | 21 | 20 | 14 |
| Colesterol - LDL | 20 | 19 | 15 |
| Colesterol - VLDL** | 17 | 16 | 16 |
| Colesterol in lichid de punctie (CHOLP)* | 47 | 45 | 3180 |
| Colesterol total | 15 | 14 | 13 |
| Colinesteraza** | 29 | 27 | 1407 |
| COMP - Proteina Matrice Oligomerica a Cartilajului (COMP)* | 200 | 194 | 5777 |
| Complement C1q (C1K)* | 155 | 150 | 5672 |
| Complement C2 (C2K)* | 135 | 130 | 1529 |
| Complement C3 | 32 | 30 | 104 |
| Complement C3 in lichid de punctie (C3KP)* | 78 | 74 | 4795 |
| Complement C4 | 32 | 30 | 193 |
| Complement C5 (C5K)* | 135 | 130 | 1850 |
| Complement C9 (C9K)* | 85 | 81 | 3369 |
| Coprocitograma** | 38 | 36 | 1385 |
| Coprocultura | 56 | 53 | 1228 |
| Coprocultura (ex. micologic) | 60 | 57 | 2868 |
| Coproporfirine urinare (KOPU24)* | 275 | 269 | 1492 |
| Corpi cetonici - cetone totale, acetoacetat, butirat (ACAC,GKETO,BUTY)* | 314 | 307 | 4656 |
| Corticosteroid-binding globulin (Transcortin) (CBG)* | 360 | 352 | 5783 |
| Cortizol din urina spontana (CORTT)* | 80 | 76 | 5241 |
| Cortizol in urina (CORU)* | 72 | 69 | 2107 |
| Cortizol salivar (CORTSL)* | 88 | 84 | 2259 |
| Cortizol seric | 56 | 53 | 70 |
| Cotinina in ser (COTI)* | 560 | 548 | 3069 |
| Cotinina in urina (COTIU)* | 560 | 548 | 2464 |
| Coxiella burnetii Anticorpi IgG - faza 2(CO2GE)* | 198 | 192 | 5552 |
| Coxiella burnetii Anticorpi IgM - faza 2(CO2ME)* | 127 | 123 | 2623 |
| Creatina urinara (KRETPS)* | 231 | 226 | 1711 |
| Creatinina | 15 | 14 | 18 |
| Creatinina in lichid de punctie (KREAP)* | 57 | 54 | 3181 |
| Creatinina urinara | 22 | 21 | 19 |
| CRH-hormon de eliberare a corticotropinei* | 365 | 357 | 5370 |
| Crioglobuline** | 40 | 38 | 1304 |
| Crom (CR)* | 120 | 116 | 1639 |
| Crom urinar (CRU)* | 115 | 111 | 2180 |
| Cryptococcus neoformans Ag in LCR (CNAGAL)* | 155 | 150 | 2634 |
| Cryptococcus neoformans Ag in ser (CNAGA)* | 160 | 155 | 4606 |
| Cupru in eritrocite (CUEMT)* | 80 | 75 | 5984 |
| Cupru in sange integral (CUVB)* | 94 | 90 | 3581 |
| Cupru seric (CU)* | 62 | 59 | 2189 |
| Cupru urinar (CU24H)* | 72 | 69 | 2190 |
| CXCL13 in LCR (CXC13L)* | 287 | 281 | 5175 |
| Cyclosporina A(CYCLO)* | 313 | 306 | 2098 |
| CYFRA 21-1* | 66 | 63 | 1264 |
| Cystatin C (CYSCG)* | 100 | 96 | 1801 |
| Babesia ADN-PCR (BABPCR)* | 480 | 470 | 1510 |
| Babesia ADN-PCR in capusa (BABPCZ)* | 330 | 323 | 2276 |
| Babesia microti Ac IgG (BABGI)* | 180 | 174 | 5802 |
| Barbiturice (BAR) in urina - screening** | 106 | 102 | 5736 |
| Barbiturice in ser (BARB)* | 155 | 150 | 2018 |
| Bartonella henselae - Ac IgG si IgM (KATZE)* | 220 | 215 | 4402 |
| Bartonella henselae ADN-PCR in tesut biopsie/punctie (BAHPCR)* | 606 | 593 | 2335 |
| Bartonella henselae si quintana Ac IgG si IgM (BART)* | 352 | 344 | 4403 |
| BCL1/ICH,t(11,14)(q13;q32) - FISH* | 995 | 995 | 5698 |
| BCL1/ICH,t(11,14)(q13;q32) - PCR* | 485 | 485 | 5699 |
| BCR/ABL - t(;22) FISH* | 800 | 800 | 4454 |
| BCR/ABL - t(9;22) cuantificare (P190, P210), RT-PCR* | 800 | 800 | 4695 |
| BDNF-factor neurotrofic derivat din creier (BDNF)* | 209 | 204 | 2698 |
| Benzen (BZOL)* | 390 | 382 | 5833 |
| Benzi oligoclonale si Index IgG LCR/ser, Imunofixare (OLIGO)* | 280 | 274 | 5676 |
| Benzodiazepine (BZO) in urina - screening** | 111 | 107 | 3208 |
| Benzodiazepine in ser (BENZ)* | 496 | 486 | 2017 |
| Beriliu in urina (BERU)* | 428 | 419 | 2226 |
| Beta 2 Microglobulina | 77 | 73 | 1550 |
| Beta 2 Microglobulina in LCR (B2MIL)* | 95 | 91 | 2710 |
| Beta 2 Microglobulina urinara (B2MIU)* | 105 | 101 | 1804 |
| Beta Amiloid raport 42/40 in LCR (AMYLIQ)* | 374 | 366 | 2713 |
| Beta caroten (CARO)* | 176 | 170 | 1591 |
| Beta Galactocerebrozidaza (BGALCB)* | 220 | 215 | 2999 |
| Beta Glucuronidaza, inclusiv Beta Galactozidaza* | 385 | 377 | 2257 |
| Beta HCG-marker tumoral in lichid de punctie (HCGTP)* | 92 | 88 | 4939 |
| Beta Thalassemia, panel HBB - PCR* | 1300 | 1300 | 6021 |
| Beta-2-Transferina (B2TNS)* | 396 | 388 | 3611 |
| Beta-crosslaps (CTX)** | 66 | 63 | 1342 |
| Beta-D-Glucan (BDGLU)* | 415 | 406 | 4348 |
| Beta-defensina in materii fecale (BDEFST)* | 110 | 106 | 5107 |
| Beta-hidroxibutirat (acid beta-hidroxibutiric) (HBUT)* | 150 | 145 | 5832 |
| Bilirubina directa(conjugata) | 14 | 13 | 8 |
| Bilirubina indirecta(neconjugata)** | 15 | 14 | 9 |
| Bilirubina totala | 15 | 14 | 10 |
| Biomarkeri pentru tumori solide - panel extins 500 gene - NGS* | 12000 | 12000 | 5648 |
| Biopsia lichida - biomarkeri de ADN tumoral, panel de 52 de gene - mutatii, amplificari si rearanjari (translocatii si fuziuni) - secventiere NGS* | 10500 | 10500 | 5211 |
| Biotinidaza - activitate (BIOTA)* | 325 | 318 | 5368 |
| Biotinidaza din picatura de sange pe hartie-filtru (BIOT)* | 165 | 160 | 2373 |
| Biperiden (BIPER)* | 400 | 392 | 4845 |
| Bisfenol A in urina (BISPA)* | 428 | 419 | 4817 |
| Bisoprolol (BISOP)* | 390 | 382 | 4648 |
| BNP-NT-Propeptid | 160 | 155 | 1621 |
| Boala Alzheimer - predispozitie genetica - gena PSEN1, secventiere* | 2200 | 2200 | 4674 |
| Boala Alzheimer - predispozitie genetica - gena PSEN2, secventiere (PSEN2)* | 5600 | 5600 | 5296 |
| Boala chistica renala (nefronoftizis) - screening 19 gene - secventiere* | 6800 | 6800 | 4673 |
| Boala Creutzfeld Jacobs (E200K - PRNP) - secventiere* | 1500 | 1500 | 5531 |
| Boala Creutzfeld Jacobs (PRNP) - secventiere* | 1600 | 1600 | 5530 |
| Boala Danon - proteina membranara 2 asociata lizozomilor (LAMP2)* | 2310 | 2286 | 4885 |
| Boala Danon (cardiomiopatie vacuolara si miopatie cu transmitere legata de X) - gena LAMP2 - secventiere* | 3500 | 3500 | 4884 |
| Boala ficatului polichistic - panel complex de 6 gene - PLUS, SEQ, DEL/DUP (GA0201)* | 3600 | 3600 | 5475 |
| Boala granulomatoasa cronica - panel complex de 8 gene - PLUS, SEQ, DEL/DUP (IM0601)* | 3600 | 3600 | 5447 |
| Boala Hirschprung - panel complex de 15 gene - PLUS, SEQ, DEL/DUP (MA1801)* | 3600 | 3600 | 5472 |
| Boala Niemann-Pick - tipulA/B - gena SMPD1 secventiere* | 1000 | 1000 | 5844 |
| Boala Parkinson - panel 82 de gene - PLUS, SEQ, DEL/DUP (NE1501)* | 4600 | 4600 | 5432 |
| Boala Parkinson cu debut timpuriu - panel de gene (PARK2, PARK6 (PINK1), PARK 7, PARK8 (LRRK2)) - secventiere NGS* | 4800 | 4800 | 4688 |
| Boala Parkinson tip 2 - gena PARK2 - MLPA* | 2200 | 2200 | 5053 |
| Boala Parkinson tip 2 - gena PARK2 - secventiere* | 1450 | 1450 | 5052 |
| Boala Pelizaeus-Merzbacher - gena PLP1 - MLPA* | 1850 | 1850 | 5850 |
| Boala Pompe - Boli cu stocare de glicogen (GAA) – secventiere* | 8000 | 8000 | 4842 |
| Boala Pompe - Boli cu stocare de glicogen – MLPA* | 1800 | 1800 | 4843 |
| Boala rinichiului polichistic - panel 10 gene - PLUS, SEQ, DEL/DUP (KI2101)* | 3600 | 3600 | 5047 |
| Boala Stargardt - gena ABCA4-secventiere* | 14000 | 14000 | 3571 |
| Boala Stargardt - gena CNGB3-secventiere* | 9500 | 9500 | 3572 |
| Boala Stargardt - gena ELOVL4-secventiere* | 6000 | 6000 | 3573 |
| Boala Tay Sachs - gena HEX-A - MLPA* | 1350 | 1350 | 5099 |
| Boala Tay Sachs - gena HEX-A - secventiere* | 4850 | 4850 | 5098 |
| Boala Tay Sachs - gena HEX-A - secventiere si MLPA* | 5900 | 5900 | 5100 |
| Boala vonWillebrand - analiza exonului 28 - subtipurile 2A, 2B, 2M* | 1000 | 1000 | 3047 |
| Boala vonWillebrand - analiza genei MLPA* | 2200 | 2200 | 3046 |
| Boala vonWillebrand - secventierea genei* | 9200 | 9200 | 3045 |
| Boala Waldenstorm, gena CXCR4 de rezistenta la Ibrutinib - secventiere* | 500 | 500 | 4722 |
| Boala Wilson - analiza MLPA a genei ATP7B* | 2000 | 2000 | 3659 |
| Boala Wilson - mutatia H1069Q in gena ATP7B* | 450 | 450 | 1597 |
| Boala Wilson - secventierea genei ATP7B* | 12300 | 12300 | 3658 |
| Boli lizozomale si mucopolizaharidoze - panel complex de 102 gene - PLUS, SEQ, DEL/DUP (ME1501)* | 4600 | 4600 | 5449 |
| Boli metabolice ereditare - panel complex de 505 gene - PLUS, SEQ, DEL/DUP (ME0701)* | 5200 | 5200 | 5427 |
| Boli oncologice hematologice si neoplazii ereditare - panel comprehensiv de 369 de gene - PLUS, SEQ, DEL/DUP (HE1401)* | 5200 | 5200 | 5463 |
| Bor in sange (BVB)* | 439 | 430 | 5318 |
| Bor in ser (B)* | 439 | 430 | 5317 |
| Bordetella pertussis Ac IgA (BORAE)* | 95 | 91 | 1782 |
| Bordetella pertussis Ac IgG (BORGE)* | 95 | 91 | 1783 |
| Bordetella pertussis Ac IgM* | 125 | 121 | 5618 |
| Bordetella pertussis ADN-PCR (BPEPCR)* | 287 | 281 | 1785 |
| Bornaprine (BORNA)* | 400 | 392 | 4846 |
| Borrelia Ac IgG** | 75 | 72 | 576 |
| Borrelia Ac IgM** | 77 | 73 | 575 |
| Borrelia ADN-PCR din LCR (LYMPCL)* | 440 | 431 | 1511 |
| Borrelia ADN-PCR din lichid de punctie/aspirat (LYMPCR)* | 441 | 432 | 3258 |
| Borrelia ADN-PCR in capusa (LYMPCZ)* | 365 | 357 | 2814 |
| Borrelia burgdorferi IgG si IgM in LCR si ser cu indice de gradient (LYMAUS)* | 440 | 431 | 5490 |
| Borrelia confirmare RN AT Imunoblot - IgG** | 190 | 184 | 2611 |
| Borrelia confirmare RN AT Imunoblot - IgM** | 170 | 164 | 5346 |
| Borrelia Limfocite CD3-CD57+ (LYDBO)* | 320 | 313 | 2735 |
| BRCA + 16 GENES - panel 18 gene implicate in cancerul de san, ovar, endometru* | 2700 | 2700 | 4466 |
| BRCA 2 - analiza unei mutatii familiale* | 1150 | 1150 | 4469 |
| BRCA1 - analiza MLPA* | 950 | 950 | 3732 |
| BRCA1, BRCA2 - analiza MLPA* | 2000 | 2000 | 5506 |
| BRCA2 - analiza MLPA* | 950 | 950 | 3733 |
| Brivaracetam (BRIVA)* | 400 | 392 | 4763 |
| Brom in ser (BR)* | 120 | 116 | 2220 |
| Bromocriptina (BRCRI)* | 400 | 392 | 4847 |
| Brucella abortus IgG* | 110 | 106 | 4943 |
| Brucella abortus IgM* | 95 | 91 | 4944 |
| Brucella ADN-PCR (BRUPCR) | 745 | 707 | 6040 |
| Brucella spp. (canis, abortus, melitensis, suis) Ac IgG (BRUGE)* | 140 | 135 | 4941 |
| Brucella spp. (canis, abortus, melitensis, suis) Ac IgM (BRUME)* | 140 | 135 | 4942 |
| Buprenorfine (BUP) in urina - screening** | 106 | 102 | 5739 |
| ABCB4, ABCB11 - secventiere NGS* | 9000 | 9000 | 4671 |
| Acetazolamida in sange (ACETA)* | 420 | 411 | 5876 |
| Acetona in urina (ACETU)* | 216 | 211 | 2182 |
| Acid 2-tio-tiazolidin-4-carboxilic in urina (TTCA)* | 300 | 291 | 5971 |
| Acid 5-hidroxindol acetic urinar (5-HIAA) (HIESUT)* | 150 | 145 | 1566 |
| Acid 5-hidroxitriptofan (5-HPT) (H5TRYP)* | 220 | 215 | 5880 |
| Acid 5-hidroxitriptofan in urina (5-HPT) (H5TRYU)* | 220 | 215 | 5881 |
| Acid delta amino-levulinic dehidrataza (ALAD)* | 132 | 128 | 2492 |
| Acid delta amino-levulinic in urina (ALAU)* | 210 | 205 | 2200 |
| Acid fenilglioxilic (PGLYU)* | 106 | 102 | 3290 |
| Acid fenilmercapturic in urina (PMER)* | 439 | 430 | 2208 |
| Acid glutamic in urina (GLUSU)* | 165 | 160 | 3712 |
| Acid hialuronic (HYAS)* | 175 | 169 | 1460 |
| Acid hipuric urinar (AHIPUK)* | 109 | 105 | 2183 |
| Acid homogentisinic (HGENU)* | 407 | 398 | 1483 |
| Acid homovanilic (HVA24)* | 175 | 169 | 2165 |
| Acid homovanilic in LCR* | 297 | 291 | 3268 |
| Acid lipoic (LIPON)* | 320 | 313 | 5877 |
| Acid mandelic in urina (MAND)* | 115 | 111 | 2209 |
| Acid metilhipuric in urina (MHIPPU)* | 230 | 225 | 2184 |
| Acid metilimidazol acetic (metabolit al histaminei) (MIESUK)* | 210 | 205 | 4738 |
| Acid metilmalonic in ser (MMALO)* | 335 | 328 | 5691 |
| Acid metilmalonic in urina (MMALU)* | 335 | 328 | 5692 |
| Acid micofenolic - micofenolat (MYCOP)* | 207 | 202 | 5550 |
| Acid oxalic in ser* | 164 | 159 | 5628 |
| Acid oxalic in urina (OXAU24)* | 164 | 159 | 2185 |
| Acid palmitic (PALM)* | 407 | 398 | 2927 |
| Acid phytanic (PHYT)* | 395 | 387 | 2519 |
| Acid pipecolic (PIPS)* | 374 | 366 | 2665 |
| Acid pristanic (PRIS)* | 451 | 441 | 3017 |
| Acid sialic (SIAL)* | 275 | 269 | 5882 |
| Acid stearic (STEA)* | 407 | 398 | 2928 |
| Acid trans muconic in urina* | 170 | 164 | 4667 |
| Acid tricloracetic in urina (TCLSU)* | 153 | 148 | 2186 |
| Acid uric | 15 | 14 | 577 |
| Acid uric din lichid de punctie (HSP)* | 30 | 28 | 3299 |
| Acid uric urinar** | 19 | 18 | 4 |
| Acid vanil mandelic (VMAT)* | 65 | 62 | 1399 |
| Acidemia glutarica tip 1 - gena GCDH secventiere* | 2500 | 2500 | 4733 |
| Acidemia/acidurie organica si deficienta de cobalamina - panel complex 54 gene - PLUS (ME0901)* | 4600 | 4600 | 5612 |
| Aciduria argininosuccinica (ASL) - Secventiere* | 3000 | 3000 | 4728 |
| Acilcarnitina in urina (CARNU)* | 550 | 539 | 3392 |
| Acizi biliari in materii fecale (GALST)* | 127 | 123 | 3074 |
| Acizi biliari** | 127 | 123 | 1758 |
| Acizi grasi HS-Omega-3-index (HSO3I)* | 506 | 495 | 3432 |
| Acizi grasi liberi (FFS)* | 110 | 106 | 1618 |
| Acizi organici in urina (ORGSU)* | 950 | 931 | 5560 |
| Acizi si saruri biliare - diferentiere in ser* | 528 | 517 | 5356 |
| Acondroplazia - gena FGFR3 - secventiere exon 10* | 4000 | 4000 | 5835 |
| ACTH-hormon adenocorticotrop | 70 | 67 | 69 |
| Activitatea Alfa - Sinucleinei in LCR* | 1950 | 1850 | 5951 |
| Activitatea anti Factor X Activat (Heparina) (AFA10A)** | 225 | 220 | 2030 |
| Activitatea anti Factor Xa - Spiegel (Apixaban) (AF10AE)* | 172 | 166 | 4440 |
| Activitatea anti Factor Xa (Rivaroxaban) (AFA10X)* | 187 | 181 | 5254 |
| Activitatea inhibitorie a melanomului (MIA)* | 275 | 269 | 5279 |
| Adalimumab (monitorizarea terapiei) (ADALI)* | 379 | 371 | 3236 |
| ADAMTS13 (factor de clivare von Willebrand) - activitate, anticorpi, antigen (ADAM)* | 420 | 411 | 5900 |
| Adenovirus - Antigen in materii fecale - screening** | 52 | 49 | 1795 |
| Adenovirus - Antigen in materii fecale - test ELISA (ADE)* | 88 | 84 | 2303 |
| Adenovirus Ac IgG (AVGE)* | 73 | 70 | 1841 |
| Adenovirus Ac IgM (AVME)* | 75 | 72 | 1803 |
| Adenovirus ADN-PCR in exsudat faringian/ secretie conjunctivala (AVPCR)* | 650 | 637 | 5800 |
| Adenovirus ADN-PCR in LCR (AVPCL)* | 287 | 281 | 2707 |
| Adenozin-deaminaza - determinare in lichid de punctie (ADDAP)* | 660 | 646 | 4450 |
| Adenozin-deaminaza 2 - test enzimatic (ADA2)* | 1375 | 1361 | 5103 |
| Adenozin-deaminaza in ser (ADDA)* | 695 | 681 | 2738 |
| ADH precursor - CT-Pro-AVP (Provasopresina, Copeptina) (COPEP)* | 295 | 289 | 5693 |
| Adiponectina (ADIN)* | 215 | 210 | 1306 |
| ADN bacterian - PCR in lichid de punctie (ARN 16s) (BAKPCR)* | 287 | 281 | 3579 |
| ADN Mitocondrial - deletii ale genomului mitocondrial pentru sindroamele Kearns-Sayer, Pearson si CPEO* | 1150 | 1150 | 3600 |
| Adrenalina (ADRE)* | 205 | 200 | 1619 |
| Aflatoxine B1, B2, G1, G2 (AFT)* | 450 | 441 | 2631 |
| AFP in lichid amniotic (AFPF)* | 105 | 101 | 2273 |
| AFP-alfa1fetoproteina(ficat,sarcina) | 85 | 81 | 5694 |
| Albumina | 17 | 16 | 6 |
| Albumina din LCR (ALBL)* | 57 | 54 | 1539 |
| Albumina in lichid de punctie (ALBP)* | 40 | 38 | 2883 |
| Alcool etilic (etanol) in urina - screening | 30 | 28 | 5955 |
| Alcool metilic (metanol) in sange-EDTA (MALK)* | 230 | 225 | 2298 |
| Alcool metilic (metanol) in urina* | 245 | 240 | 5746 |
| Aldolaza in ser (ALDOL)* | 160 | 155 | 1314 |
| Aldosteron (ALDOS)** | 150 | 145 | 1358 |
| Aldosteron in urina (ALDOSU)* | 170 | 164 | 1640 |
| ALEX 2 (Allergy Explorer - test multiplex IgE specific 295 alergeni)** | 790 | 774 | 5091 |
| Alfa 1 Antitripsina (AAT)** | 60 | 57 | 1295 |
| Alfa 1 Antitripsina fenotipare (AATPT)* | 165 | 160 | 1881 |
| Alfa 1 Antitripsina in materii fecale (AATST)* | 120 | 116 | 1771 |
| Alfa 1 Glicoproteina (A1GLY)* | 77 | 73 | 1556 |
| Alfa 1 Microglobulina (A1MI)* | 95 | 91 | 5650 |
| Alfa 1 Microglobulina in urina 24H (A1MUT)* | 95 | 91 | 5652 |
| Alfa 1 Microglobulina in urina spontana (A1MIUK)* | 95 | 91 | 5651 |
| Alfa 1-antitripsina (SERPINA1) - genotipare ARMS-PCR* | 450 | 450 | 4548 |
| Alfa 1-antitripsina (SERPINA1) - secventierea* | 1600 | 1600 | 4549 |
| Alfa 2 Macroglobulina (A2MA)* | 61 | 58 | 1466 |
| Alfa Enolaza - BLOT (AENO)* | 138 | 133 | 5072 |
| Alfa Glucozidaza 1 (AGLU1)* | 248 | 243 | 3559 |
| Alfa Glucozidaza in sperma (GLUAEJ)* | 180 | 174 | 5860 |
| Alfa Thalassemie - gena HBA - MLPA* | 1950 | 1950 | 3367 |
| Alfa Thalassemie - gena HBA - secventiere* | 3600 | 3600 | 3368 |
| Alfa-2 antiplasmina (inhibitor de plasmina) (A2APL)* | 205 | 200 | 5499 |
| Alfa-Galactozidaza in ser (AGAL)* | 138 | 133 | 3444 |
| Alfa-Iduronidaza - MPZ I Hurler-Scheie (AIDU)* | 220 | 215 | 2316 |
| Alfa-N-acetilgalactozaminidaza(Nagalaza) (NAGA)* | 638 | 625 | 3330 |
| Aluminiu seric (AL)* | 131 | 127 | 2188 |
| Aluminiu urinar (ALU)* | 121 | 117 | 1617 |
| AMA - anticorpi anti-mitocondriali (AMA)** | 110 | 106 | 1400 |
| AMA-M2 (AMA2)* | 149 | 144 | 1736 |
| AMA-M4 (AMA4)* | 105 | 101 | 3281 |
| AMA-M9 (AMA9)* | 105 | 101 | 3282 |
| Amantadina (AMANT)* | 400 | 392 | 4844 |
| Amfetamine (AMP) in urina - screening** | 106 | 102 | 3054 |
| Amfetamine in firul de par (AMPHAA)* | 386 | 378 | 4347 |
| Amfetamine în urina - confirmare si identificare (AMPUBU)* | 386 | 378 | 3576 |
| Amfetamine/Metamfetamine - test de screening in ser (AMPHSE)* | 387 | 379 | 2014 |
| Amilaza | 18 | 17 | 40 |
| Amilaza in lichid de punctie (AMYLP)* | 17 | 16 | 2176 |
| Amilaza - izoenzime (alfa-amilaza, amilaza pancreatica, amilaza salivara) (AMISO) | 75 | 72 | 2473 |
| Amilaza pancreatica serica** | 25 | 24 | 1634 |
| Amilaza urinara (AMY24)* | 24 | 23 | 41 |
| Amilaza urinara (urina spontana)* | 12 | 12 | 4905 |
| Amiloid A in ser (SAA)* | 110 | 106 | 2942 |
| Amine biogene in LCR (acid homovanilic, acid 5-hidroxiindolacetic, 3-orto-metildopa, L-Dopa, 5-hidroxitriptofan, raport HVA) (BIOL)* | 1073 | 1062 | 4988 |
| Aminoacizi din picatura de sange pe hartie-filtru (AMSFI)* | 440 | 431 | 3362 |
| Aminoacizi screening in LCR (AMINOL)* | 694 | 680 | 4713 |
| Aminoacizi screening in plasma (AMSPP)* | 440 | 431 | 1589 |
| Aminoacizi screening in urina (AMINOU)* | 215 | 210 | 1836 |
| Amiodarona in ser (AMI)* | 165 | 160 | 2135 |
| Amiotrofie spinala (genele SMN1 si SMN 2) - MLPA* | 2000 | 2000 | 5507 |
| Amiotrofie spinala tip I/II/III gena SMN 1 in lichid amniotic* | 5100 | 5100 | 1814 |
| Amiotrofie spinala tip I/II/III gena SMN 1 in vilozitati coriale* | 4250 | 4250 | 3002 |
| Amitriptilina si metabolitul Nortriptilina (AMNO)* | 400 | 392 | 4856 |
| Amniocultura** | 170 | 164 | 2896 |
| Amoxicillin (AMOXI)* | 445 | 436 | 5558 |
| Amprenta anala** | 48 | 46 | 1389 |
| ANA - PANEL 23 ANTIGENE NUCLEARE BLOT EXTINS (ADNds, nucleosome, histone, SS-A, Ro52, SS-B, nRNP/Sm, Mi-2 beta, Mi-2 alfa, Ku, CENP A, CENP B, Sp100, PML, Scl 70, PM-Scl 100, PM-Scl 75, RP 11, RP 155, gp 210, PCNA, DFS 70)** | 275 | 269 | 4822 |
| ANA - PANEL 3 BLOT EXTINS (U1nRNP, Sm, SS-A, Ro52, SS-B, Scl-70, Pm-Scl, Jo-1, Centromer B, PCNA, ADNds, Nucleosom, Histone, Proteina P ribosomala, AMA-M2, DFS-70)** | 185 | 179 | 4776 |
| ANA - screening Ac IgG - Imunofluorescenta** | 68 | 65 | 2615 |
| ANA - screening si titrare Ac IgG - Imunofluorescenta** | 106 | 102 | 1290 |
| ANA - titrare Ac IgA, IgG, IgM - Imunofluorescenta** | 235 | 230 | 5695 |
| Analiza firului de par (elemente toxice si minerale) - test extins (MMINPE)* | 1055 | 1044 | 3327 |
| Analiza firului de par (elemente toxice si minerale) - test standard (MMINPH)* | 835 | 818 | 3326 |
| Analiza mutatiilor familiale cunoscute in genele MSH6 si BPTF* | 1100 | 1100 | 5378 |
| ANCA (cANCA+pANCA)* | 122 | 118 | 1371 |
| Androgen index-free (FAI)* | 165 | 160 | 1945 |
| Androstandiol glucuronid (ANDOL)* | 187 | 181 | 3239 |
| Androstendion seric (ANDRO)** | 133 | 129 | 1369 |
| Anemia Diamond-Blackfan - panel complex de 14 de gene - PLUS, SEQ, DEL/DUP (HE0901)* | 3600 | 3600 | 5471 |
| Aneuploidii in alte produse biologice (X, Y, 13, 18, 21) - QF-PCR* | 600 | 600 | 4928 |
| Aneuploidii in lichid amniotic (X, Y, 13, 18, 21) - QF-PCR* | 700 | 700 | 3681 |
| Aneuploidii in sange EDTA (X, Y, 13, 18, 21) - QF-PCR* | 600 | 600 | 4927 |
| Aneuploidii in sperma (X, Y, 13, 15, 16, 17, 18, 21, 22) - FISH* | 2900 | 2900 | 5382 |
| Aneuploidii in sperma (X, Y, 13, 16, 18, 21, 22) - FISH* | 1500 | 1500 | 5383 |
| Aneuploidii in sperma (X, Y, 13, 18, 21) - FISH* | 1400 | 1400 | 4771 |
| Aneuploidii in sperma (X, Y, 18) - FISH* | 1300 | 1300 | 5381 |
| Aneuploidii X-Y (analiza sexului cromosomial)* | 650 | 650 | 5384 |
| Angioedem ereditar - gena SERPING1 - secventiere* | 1500 | 1500 | 5510 |
| Angioedem ereditar tip III - gena factor 12 - secventiere* | 5200 | 5200 | 4961 |
| Angiotensina II (ANGIO2)* | 286 | 280 | 5126 |
| Angiotensinconvertaza (ACE)* | 95 | 91 | 5682 |
| Angiotensinconvertaza in LCR (ACEL)* | 127 | 123 | 3424 |
| Anisakis Ac IgG (ANISGI)* | 99 | 95 | 4445 |
| Anti Factor II - Activitate (Dabigatran-Pradaxa) (AFA2D)* | 165 | 160 | 4441 |
| Anti Mulleriane Hormone (AMH) | 195 | 189 | 1532 |
| Anti Receptor TSH (TRAB)** | 110 | 106 | 612 |
| Anti-asialoglicoprotein receptor (ASGP-R)* | 130 | 126 | 5836 |
| Anti-IgLON5 in LCR (IGL5IL)* | 245 | 240 | 5885 |
| Anti-IgLON5 in ser (IGLO5I)* | 250 | 245 | 5811 |
| Antibiograma (la cerere) | 20 | 19 | 3068 |
| Anticoagulant Lupic (LAB)** | 120 | 116 | 1415 |
| Anticorpi ADA (Adalimumab) (anticorpi anti-TNF-alfa - eficienta terapeutica) (ADALAK)* | 275 | 269 | 3237 |
| Anticorpi anti - Imunoglobulina A (IGAA)* | 115 | 111 | 4721 |
| Anticorpi anti - mGluR5 - IgG (MGLUR5)* | 105 | 101 | 5770 |
| Anticorpi anti acetilcolin receptor (ACRH)* | 182 | 176 | 1453 |
| Anticorpi anti acini de glanda salivara (SPEIAZ)* | 94 | 90 | 2071 |
| Anticorpi anti actina (ACTA)* | 110 | 106 | 2116 |
| Anticorpi anti ADN dublu catenar-DS (DDNSE)* | 105 | 101 | 1307 |
| Anticorpi anti ADN dublu catenar-DS in LCR (DDNSEL)* | 132 | 128 | 2752 |
| Anticorpi anti ADN monocatenar-SS (SDNSE)* | 110 | 106 | 1449 |
| Anticorpi anti adreno-cortex (NNA)* | 105 | 101 | 1692 |
| Anticorpi anti Agrin IgG (AGRING)* | 170 | 164 | 5921 |
| Anticorpi anti Amfifizina (AMPHI1)* | 250 | 245 | 5878 |
| Anticorpi anti Amfifizina 1 in LCR (AMPH1L)* | 250 | 245 | 5867 |
| Anticorpi anti Annexin V IgG (ANNV)* | 110 | 106 | 1902 |
| Anticorpi Anti Aspergillus fumigatus (ASFUH)* | 135 | 130 | 1797 |
| Anticorpi anti BPI (proteine ce cresc permeabilitatea bactericida) (BPI)* | 130 | 126 | 5902 |
| Anticorpi anti canal de calciu tip N (CAKN)* | 350 | 343 | 5684 |
| Anticorpi anti canal de calciu tip N in LCR (CAKNL)* | 330 | 323 | 2745 |
| Anticorpi anti canal de calciu tip PQ (CAKPQ)* | 343 | 336 | 2237 |
| Anticorpi anti canal de calciu tip PQ in LCR (CAKPQL)* | 330 | 323 | 2746 |
| Anticorpi anti canale de potasiu in LCR (KKAKL)* | 220 | 215 | 5813 |
| Anticorpi anti canale de potasiu voltaj-dependente (KKAK)* | 232 | 227 | 2158 |
| Anticorpi anti Candida albicans IgA (CANAE)* | 110 | 106 | 2118 |
| Anticorpi anti Candida albicans IgG (CANGE)* | 94 | 90 | 2119 |
| Anticorpi anti Candida albicans IgM (CANME)* | 94 | 90 | 2120 |
| Anticorpi anti Cardiolipina IgA, IgG, IgM (ACLA)* | 166 | 161 | 3412 |
| Anticorpi anti CASPR2 (Contactin-associated protein 2) in LCR (CASPRL)* | 245 | 240 | 5870 |
| Anticorpi anti CASPR2 (Contactin-associated protein 2) in ser (CASPR2)* | 250 | 245 | 5931 |
| Anticorpi anti catepsina G (CATG)* | 115 | 111 | 5915 |
| Anticorpi anti CCP - Peptidul ciclic citrulinat** | 85 | 81 | 1392 |
| Anticorpi anti celula endoteliala (EZA)* | 90 | 86 | 2203 |
| Anticorpi anti celule insulare (ICAT)* | 135 | 130 | 1504 |
| Anticorpi anti celule parietale gastrice (PARIA)** | 110 | 106 | 1606 |
| Anticorpi anti centromer** | 110 | 106 | 5689 |
| Anticorpi anti citocrom P450-c17-hidroxilaza (PC17H)* | 105 | 101 | 2405 |
| Anticorpi anti citocrom P450-scc-hidroxilaza (PSCCH)* | 90 | 86 | 2404 |
| Anticorpi anti colagen tip VII IgG (KOLL7)* | 115 | 111 | 5789 |
| Anticorpi anti Contactin 1 in LCR (CNTN1L)* | 281 | 275 | 5117 |
| Anticorpi anti Contactin 1 in ser (CASPR1)* | 282 | 276 | 5116 |
| Anticorpi anti CRMP5 in LCR (Oligodendrocite) (CRMP5L)* | 145 | 140 | 2584 |
| Anticorpi anti CRMP5 in ser (Oligodendrocite) (CRMP5)* | 143 | 138 | 2585 |
| Anticorpi anti CV-2 in LCR (CV2L)* | 250 | 245 | 5794 |
| Anticorpi anti desmogleina 1 (DES1)* | 176 | 170 | 2493 |
| Anticorpi anti Desmogleina 3 (DES3)* | 187 | 181 | 4986 |
| Anticorpi anti desmozom (pemfigus) (STAK)* | 121 | 117 | 2491 |
| Anticorpi anti DFS 70 (DFS70)* | 121 | 117 | 3588 |
| Anticorpi anti Endomysium IgA (EMAA)* | 127 | 123 | 1526 |
| Anticorpi anti Endomysium IgG (EMAG)* | 182 | 176 | 1527 |
| Anticorpi anti Endomysium IgM* | 132 | 128 | 4426 |
| Anticorpi anti Entamoeba histolytica (AMOGI)* | 121 | 117 | 1580 |
| Anticorpi anti enterocitari (AIE)* | 209 | 204 | 2267 |
| Anticorpi anti epiteliu acini de glanda salivara (SPEIBA)* | 105 | 101 | 2072 |
| Anticorpi anti eritrocitari - SCREENING** | 250 | 245 | 3110 |
| Anticorpi anti eritrocitari - TITRARE** | 245 | 240 | 4427 |
| Anticorpi anti eritropoietina (ERYTH)* | 195 | 189 | 3050 |
| Anticorpi anti factor intrinsec** | 105 | 101 | 1518 |
| Anticorpi anti factor IX (AFA9)* | 163 | 158 | 3029 |
| Anticorpi anti factor VIII (AFA8)* | 175 | 169 | 5677 |
| Anticorpi anti Fasciola Hepatica (FASE)* | 215 | 210 | 4533 |
| Anticorpi anti fodrin (spectrina non-eritroida) IgA (FODAE)* | 110 | 106 | 2572 |
| Anticorpi anti fodrin (spectrina non-eritroida) IgG (FODGE)* | 110 | 106 | 2573 |
| Anticorpi anti fosfatidil-glicerol IgG (PHGLG)* | 78 | 74 | 3363 |
| Anticorpi anti fosfatidil-glicerol IgM (PHGLM)* | 78 | 74 | 3323 |
| Anticorpi anti fosfatidil-inozitol IgG (PHING)* | 78 | 74 | 3119 |
| Anticorpi anti fosfatidil-inozitol IgM (PHINM)* | 90 | 86 | 3120 |
| Anticorpi anti fosfatidil-serina IgA (PHSEA)* | 115 | 111 | 5729 |
| Anticorpi anti fosfatidil-serina IgG (PHSEG)* | 115 | 111 | 5730 |
| Anticorpi anti fosfatidil-serina IgM (PHSEM)* | 115 | 111 | 5731 |
| Anticorpi anti Fosfolipidici IgG* | 77 | 73 | 1326 |
| Anticorpi anti Fosfolipidici IgM* | 77 | 73 | 1777 |
| Anticorpi anti gangliozide-mielina 1 IgG (GM1G)* | 160 | 155 | 2812 |
| Anticorpi anti gangliozide-mielina 1 IgG in LCR (GMGL)* | 106 | 102 | 2780 |
| Anticorpi anti gangliozide-mielina 1 IgM (GM1M)* | 160 | 155 | 2813 |
| Anticorpi anti gangliozide-mielina 1 IgM in LCR (GMML)* | 106 | 102 | 2781 |
| Anticorpi anti gangliozide-mielina 2 IgG (GM2G)* | 106 | 102 | 3075 |
| Anticorpi anti gangliozide-mielina 2 IgM (GM2M)* | 106 | 102 | 3076 |
| Anticorpi anti gangliozide-mielina IgG - BLOT complet: GM1, GM2, GM3, GD1A, GD1B, GQ1B, GT1B (GMPG)* | 171 | 165 | 3287 |
| Anticorpi anti gangliozide-mielina IgM - BLOT complet: GM1, GM2, GM3, GD1A, GD1B, GQ1B, GT1B (GMPM)* | 182 | 176 | 3288 |
| Anticorpi anti Glicoproteina oligodendrocitara a mielinei (MOGI)** | 250 | 245 | 5907 |
| Anticorpi anti Glicoproteina oligodendrocitara a mielinei in LCR (MOGIL)* | 245 | 240 | 5879 |
| Anticorpi anti GM-CSF (Granulocite-Macrofage)* | 150 | 145 | 6017 |
| Anticorpi Anti grup sangvin A - detectie** | 74 | 71 | 3727 |
| Anticorpi Anti grup sangvin A - titrare** | 110 | 106 | 3730 |
| Anticorpi Anti grup sangvin B - detectie** | 66 | 63 | 3728 |
| Anticorpi Anti grup sangvin B - titrare** | 110 | 106 | 3731 |
| Anticorpi Anti grup sangvin RHo(D) - detectie si identificare** | 74 | 71 | 3726 |
| Anticorpi Anti grup sangvin RHo(D) - titrare** | 160 | 155 | 3729 |
| Anticorpi anti Haemophilus influenzae tip B IgG postvaccinali (HIBGE)* | 106 | 102 | 5097 |
| Anticorpi anti hialuronidaza (AHYA)* | 130 | 126 | 5749 |
| Anticorpi anti HMG-CoA-reductaza (HMGCR)* | 115 | 111 | 5040 |
| Anticorpi anti Hu-D (HU)* | 105 | 101 | 1888 |
| Anticorpi anti Hu-D in LCR - BLOT (HUBL)* | 200 | 194 | 5732 |
| Anticorpi anti Hu-D in LCR (HUL)* | 105 | 101 | 2703 |
| Anticorpi anti infliximab (INFXAK)* | 390 | 382 | 3125 |
| Anticorpi anti influenza A IgA (INAAE)* | 106 | 102 | 3394 |
| Anticorpi anti influenza A IgG (INAGE)* | 111 | 107 | 3395 |
| Anticorpi anti influenza B IgA (INBAE)* | 111 | 107 | 3397 |
| Anticorpi anti influenza B IgG (INBGE)* | 111 | 107 | 3398 |
| Anticorpi anti insulina (IAA)* | 121 | 117 | 1503 |
| Anticorpi anti interferon alfa (AINFE)* | 199 | 193 | 4643 |
| Anticorpi anti interferon beta (BINFE)* | 198 | 192 | 3372 |
| Anticorpi anti Jo-1 (JO1)* | 88 | 84 | 1710 |
| Anticorpi anti Ku (KUB)* | 198 | 192 | 1813 |
| Anticorpi anti LGI1 in LCR (LGI1L)* | 250 | 245 | 5812 |
| Anticorpi anti LGI1 in ser (encefalita limbica) (LGI1)* | 250 | 245 | 5795 |
| Anticorpi anti MDA5 - BLOT (MDA5B)* | 106 | 102 | 4691 |
| Anticorpi anti membrana bazala alveolara (ALVBA)* | 98 | 94 | 3297 |
| Anticorpi anti membrana bazala epidermala (EBMA)* | 176 | 170 | 2414 |
| Anticorpi anti membrana bazala glomerulara (GBMC)* | 110 | 106 | 5688 |
| Anticorpi anti Meningococcus IgG (MENAK)* | 1981 | 1961 | 5018 |
| Anticorpi anti Mi 2 (MI2)* | 143 | 138 | 1811 |
| Anticorpi anti microzomiali - LKM1* | 91 | 87 | 1283 |
| Anticorpi anti mielina asociata glycoproteinei IgM in LCR (MAGL)* | 250 | 245 | 5871 |
| Anticorpi anti mielina IgA, IgG, IgM (MAG)* | 330 | 323 | 1567 |
| Anticorpi anti muschi cardiac | 200 | 190 | 6055 |
| Anticorpi anti muschi neted (ASMA)* | 132 | 128 | 5367 |
| Anticorpi anti muschi striat (SKMA)* | 138 | 133 | 1648 |
| Anticorpi anti MuSK (tirozinkinaza musculara) (RTYRA)* | 187 | 181 | 1914 |
| Anticorpi anti Mycoplasma hominis/Ureaplasma urealyticum IgG** | 138 | 133 | 1586 |
| Anticorpi anti myosin (MYOA)* | 110 | 106 | 1649 |
| Anticorpi anti natalizumab (TYSABRI) (NATAA)* | 165 | 160 | 3373 |
| Anticorpi anti neurofascin 140 in ser* | 656 | 642 | 5118 |
| Anticorpi anti neurofascin 155 in ser (NF155)* | 293 | 287 | 5528 |
| Anticorpi anti neurofascin 186 in ser (NF186)* | 293 | 287 | 5529 |
| Anticorpi anti Neurofilamente (NEUFI)* | 250 | 245 | 5887 |
| Anticorpi anti Neurofilamente in LCR (NEUFIL)* | 250 | 245 | 5886 |
| Anticorpi anti neuronali - Hu-D, Ri, Yo (NEURO)* | 253 | 247 | 2136 |
| Anticorpi anti neuronali - NMDAR, AMPAR, GABABR, LGI1, CASPR2, GABAAR, mGluR1, mGluR2, mGluR5, DPPX, IGLON5, Neurexin, Gluk2, SEZ6L2* | 1595 | 1579 | 6002 |
| Anticorpi anti neuronali - NMDAR, AMPAR, GABABR, LGI1, CASPR2, GABAAR, mGluR1, mGluR2, mGluR5, DPPX, IGLON5, Neurexin, Gluk2, SEZ6L2 - in LCR * | 1400 | 1386 | 6003 |
| Anticorpi anti neuronali BLOT - Amphiphysin, CV2, PNMA2 (Ma2/Ta), Ri, Yo, Hu, Recoverin, AGNA (SOX1), Titin (MGT - 30)** | 530 | 519 | 5957 |
| Anticorpi anti neuronali CV2 in ser - BLOT (CV2B)* | 149 | 144 | 2968 |
| Anticorpi anti neuronali Ma1 in LCR (MA1L)* | 105 | 101 | 2774 |
| Anticorpi anti neuronali Ma2 in LCR (MA2L)* | 250 | 245 | 5869 |
| Anticorpi anti neuronali Ma2/Ta (MA2)* | 250 | 245 | 5872 |
| Anticorpi anti NOR-90 (NOR90)* | 78 | 74 | 1942 |
| Anticorpi anti nucleotidaza cN-1A IgG (miozita sIBM) (MUP44)* | 138 | 133 | 5513 |
| Anticorpi anti nucleozom (NUCLEC)* | 110 | 106 | 2917 |
| Anticorpi anti ovarieni (OVAK)* | 220 | 215 | 1968 |
| Anticorpi anti PCA-2 in LCR (PCAL)* | 250 | 245 | 5914 |
| Anticorpi anti PCNA (Proliferating Cell Nuclear Antigen)(Ciclina)** | 85 | 81 | 3066 |
| Anticorpi anti PDGFR beta (PDGFRB)* | 106 | 102 | 4783 |
| Anticorpi anti pituitari (APA) (HYPA)* | 95 | 91 | 3568 |
| Anticorpi anti PM/Scl (PMSCL)* | 154 | 149 | 1901 |
| Anticorpi anti Pneumococ IgG postvaccinali (Streptococcus pneumoniae anticorpi anti capsula polizaharidica 1-5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 20, 22F, 23F, 33F) (PNGE)* | 110 | 106 | 2839 |
| Anticorpi anti Polioma JCV-virus in LCR (JCVAKL)* | 185 | 180 | 5976 |
| Anticorpi anti Polioma JCV-virus in ser (JCVAK)* | 185 | 180 | 5975 |
| Anticorpi anti proteina acida gliala fibrilara IgG (GFAPG)* | 300 | 294 | 5847 |
| Anticorpi anti proteina acida gliala fibrilara IgG in LCR (GFAPGL)* | 330 | 323 | 5848 |
| Anticorpi anti proteina bazica a mielinei (MBP)* | 250 | 245 | 5796 |
| Anticorpi anti proteina bazica a mielinei in LCR (MBPL)* | 250 | 245 | 5868 |
| Anticorpi anti Proteina-P ribozomala (RIBGE)* | 182 | 176 | 1960 |
| Anticorpi anti proteine histone (HISTO)* | 105 | 101 | 5790 |
| Anticorpi anti protrombina-IgG (PTHAKG)* | 105 | 101 | 4935 |
| Anticorpi anti protrombina-IgM (PTHAKM)* | 106 | 102 | 4936 |
| Anticorpi anti quadrosialo gangliozid IgG (GQ1b) (GQ1BG)* | 106 | 102 | 3129 |
| Anticorpi anti receptor A2-Fosfolipaza IgG (PLA2RE)* | 116 | 112 | 3550 |
| Anticorpi anti receptor AMPA (GluR1, GluR2, AMPA-r) (AMPAR)* | 190 | 186 | 5935 |
| Anticorpi anti receptor AMPA in LCR (AMPARL)* | 180 | 176 | 5939 |
| Anticorpi anti receptor de glicina (GLYCR)* | 260 | 254 | 5793 |
| Anticorpi anti receptor GABA-A tip IgG in LCR (GABAAL)* | 260 | 252 | 5954 |
| Anticorpi anti receptor GABA-B in LCR* | 250 | 245 | 5894 |
| Anticorpi anti receptor GABA-B in ser* | 250 | 245 | 5893 |
| Anticorpi anti receptor GABA-B tip IgG in LCR (GABABL)* | 250 | 245 | 5903 |
| Anticorpi anti receptor GABA-B tip IgG in ser (GABABR)* | 250 | 245 | 5904 |
| Anticorpi anti receptor glutamat (NMDA) IgA (NMDARA)* | 250 | 245 | 5797 |
| Anticorpi anti receptor glutamat (NMDA) IgG (NMDARG)* | 250 | 245 | 5798 |
| Anticorpi anti receptor glutamat (NMDA) IgM (NMDARM)* | 250 | 245 | 5799 |
| Anticorpi anti receptor glutamat (NMDA) in LCR (NMDARL)* | 116 | 112 | 2640 |
| Anticorpi anti receptor muscarinic M3 de acetilcolina (ACHM3)* | 220 | 213 | 5963 |
| Anticorpi anti receptor Ryanodin (RYR)* | 121 | 117 | 3183 |
| Anticorpi anti Reticulina IgA* | 135 | 130 | 5641 |
| Anticorpi anti Reticulina IgG* | 135 | 130 | 5642 |
| Anticorpi anti Ri (RI)* | 144 | 139 | 2130 |
| Anticorpi anti Ri in LCR - BLOT (RIBL)* | 200 | 194 | 5733 |
| Anticorpi anti Ri in LCR (RIL)* | 105 | 101 | 2704 |
| Anticorpi anti ribonucleoproteine - U1-RNP/Sm (RNPSM)* | 105 | 101 | 5280 |
| Anticorpi anti ß2 glicoproteina IgA, IgG, IgM (B2GS)* | 160 | 155 | 3413 |
| Anticorpi anti Saccharomyces cerevisiae IgA (SCEAI)* | 110 | 106 | 1522 |
| Anticorpi anti Saccharomyces cerevisiae IgG (SCEGI)* | 135 | 131 | 5968 |
| Anticorpi anti Saccharomyces cerevisiae IgM (SCEMI)* | 121 | 117 | 1525 |
| Anticorpi anti Scl 70 (SCL70)* | 88 | 84 | 1410 |
| Anticorpi anti SLA (soluble liver Ag)/LP (liver-pancreas Ag) - Imunoblot specific hepatic si diferentiere (SLAB)* | 143 | 138 | 1700 |
| Anticorpi anti spermatozoizi (SPAK)* | 79 | 75 | 1404 |
| Anticorpi anti SRP (SRP)* | 111 | 107 | 1812 |
| Anticorpi anti SS-A-Ro (SSA)* | 99 | 95 | 1302 |
| Anticorpi anti SS-B-La (SSB)* | 91 | 87 | 1303 |
| Anticorpi anti stafilolizina (ASTA)* | 122 | 118 | 1428 |
| Anticorpi anti steroid 21-hidroxilaza (PC21H)* | 132 | 128 | 2134 |
| Anticorpi anti streptodornaza (streptococci DNAse-B) (DORN)* | 122 | 118 | 1430 |
| Anticorpi anti streptolizina (ASL)* | 85 | 81 | 5750 |
| Anticorpi anti Strongyloides - Westernblot (STROW)* | 315 | 308 | 5807 |
| Anticorpi anti Tetanus (TETE)* | 100 | 96 | 2302 |
| Anticorpi anti tiroglobulina | 53 | 50 | 623 |
| Anticorpi anti Tirozin-fosfataza (IA2)* | 110 | 106 | 2057 |
| Anticorpi anti Titin (MGT-30) (TITIN)* | 187 | 181 | 2582 |
| Anticorpi anti toxina Difterica (DIPE)* | 100 | 96 | 3366 |
| Anticorpi anti Tr (TR)* | 220 | 215 | 5901 |
| Anticorpi anti trombocitari legati IgG si IgM (THRAL)* | 187 | 181 | 2401 |
| Anticorpi anti trombocitari liberi - receptori de fibrinogen, von Willebrand si colagen (THRAF)* | 660 | 646 | 2402 |
| Anticorpi anti trombocitari liberi si legati (THROA)* | 770 | 754 | 1631 |
| Anticorpi anti U3-nRNP Fibrilarina (U3RNP)* | 128 | 124 | 1940 |
| Anticorpi anti Vimentina Citrulinata Mutanta (anti-MCV) (MCVAK)* | 105 | 101 | 2314 |
| Anticorpi anti virus parainfluenza tip 1,2,3 IgA (PIAE)* | 100 | 96 | 4768 |
| Anticorpi anti virus rabic (TOLN)* | 130 | 126 | 1375 |
| Anticorpi anti Yo (YO)* | 110 | 106 | 2131 |
| Anticorpi anti Yo in LCR - BLOT (YOBL)* | 200 | 194 | 5734 |
| Anticorpi anti Yo in LCR (YOL)* | 105 | 101 | 2705 |
| Anticorpi anti-neurocondrina (NEUCH)* | 300 | 280 | 6022 |
| Anticorpi anti-receptor de glicina in LCR (GLYCRL)* | 300 | 294 | 5775 |
| Anticorpi anti-transportor de zinc 8 si 8C (ZNT8)* | 198 | 192 | 4398 |
| Anticorpi Antinucleari Sm (SM)* | 83 | 79 | 1291 |
| Anticorpi IgG anti-insulina umana (INSA)* | 230 | 225 | 5792 |
| Anticorpi PR3 - Proteinaza 3 (PR3C)* | 83 | 79 | 4468 |
| Anticorpi Tularemia (Francisella Tularensis) IgG (TULGE)* | 130 | 126 | 2195 |
| Anticorpi Tularemia (Francisella Tularensis) IgM (TULME)* | 130 | 126 | 2196 |
| Antidepresive in urina (ADEPU)* | 390 | 382 | 3270 |
| Antidepresive triciclici in ser (TRIC)* | 335 | 328 | 2020 |
| Antitrombina – Antigen (ATAG)* | 204 | 199 | 5127 |
| Antitrombina III** | 64 | 61 | 1454 |
| Aortopatie - panel complex de 53 de gene - PLUS, SEQ, DEL/DUP (CA1001)* | 4600 | 4600 | 5421 |
| APCR - rezistenta la activarea proteinei C (APC)* | 119 | 115 | 1455 |
| Apolipoproteina A1** | 45 | 43 | 1386 |
| Apolipoproteina A1 si Apolipoproteina B - test genetic hiperlipidemie (gena APOA1, gena APOB)* | 2650 | 2650 | 3249 |
| Apolipoproteina A2 (APOLA2)* | 85 | 81 | 1601 |
| Apolipoproteina B** | 35 | 33 | 1388 |
| Apolipoproteina C2* | 440 | 431 | 4766 |
| Apolipoproteina E (APOLE)* | 94 | 90 | 2838 |
| Apolipoproteina E genotipare** | 500 | 500 | 5273 |
| Aquaporin 4 (Neuromielita optica) Ac IgG** | 245 | 230 | 6006 |
| Aquaporin 4 (Neuromielita optica) Ac totali in LCR** | 295 | 280 | 6007 |
| Argint in ser (AG)* | 125 | 121 | 5638 |
| Arilsulfataza A serica (ARSUA)* | 200 | 194 | 5874 |
| Arilsulfataza A urinara (ARSUAU)* | 200 | 194 | 5875 |
| Arilsulfataza B - MPZ VI Maroteaux-Lamy (ARSUB)* | 220 | 215 | 2318 |
| Aripiprazol (ARIPI)* | 445 | 436 | 5760 |
| Aritmia - panel complex de 58 de gene - PLUS, SEQ, DEL/DUP (CA1601)* | 4600 | 4600 | 5189 |
| Arsenic in sange (AS)* | 153 | 148 | 1980 |
| Arsenic in urina (ASU)* | 153 | 148 | 2207 |
| Ascaris Ac IgG (adult) (ASCE)* | 155 | 150 | 1861 |
| ASLO (test cantitativ) | 25 | 24 | 131 |
| Aspergillus fumigatus ADN-PCR (AFPCR)* | 387 | 379 | 5358 |
| Aspergillus fumigatus IgA (ASFAE2)* | 306 | 299 | 5546 |
| Aspergillus fumigatus IgG (ASFGE2)* | 306 | 299 | 5547 |
| Aspergillus fumigatus IgM (ASFME2)* | 306 | 299 | 5548 |
| Aspergillus galactomanan - Antigen in aspirat bronsic (ASAGEB)* | 135 | 130 | 5883 |
| Aspergillus galactomanan - Antigen in ser (ASAGE)* | 118 | 114 | 2160 |
| Ataxia - panel 257 gene - PLUS, SEQ, DEL/DUP (NE2101)* | 5200 | 5200 | 5435 |
| Ataxia Friedreich (FRDA gene)* | 1500 | 1500 | 1764 |
| Ataxia spinocerebelara de tip 3 (SCA3 gene)* | 1000 | 1000 | 4661 |
| Atenolol (ATENO)* | 390 | 382 | 4647 |
| ATPO - Ac anti tiroperoxidaza | 55 | 52 | 88 |
| Atrezia gastrointestinala - panel complex de 15 gene - PLUS, SEQ, DEL/DUP (MA2801)* | 3600 | 3600 | 5476 |
| Atrichia congenitala - mutatia genei HER (hairless gene)* | 18000 | 18000 | 4963 |
| Atrofia musculara spinala - gena SMN1 - secventiere Sanger* | 2950 | 2950 | 5516 |
| Atrofie musculara spinala si bulbara (SBMA) (Boala Kennedy)-gena AR (KENNED)* | 1500 | 1500 | 3233 |
| Aur in ser (AU)* | 417 | 408 | 2347 |
| Aur in urina (AUU)* | 384 | 376 | 2910 |
